| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 14:31 | Amgen To Near $100, Outperforming Pfizer | | 4 | Seeking Alpha |
| 11.02.
| Pfizer Recalls 1 Million Birth-Control Packs on Wrong Dosage | | 1 | Business Week |
| 10.02.
| CORRECTING and REPLACING Branham Law Group Investigates Pfizer for Packaging Error Recall | | 108 | Business Wire |
| Headline of release should read: Branham Law Group Investigates
Pfizer for Packaging Error Recall (sted Branham Law Group
Investigates Pfizer for Qualitest Packaging Error...
Mehr lesen zu:
CORRECTING and REPLACING Branham Law Group Investigates Pfizer for Packaging Error Recall | |
| 10.02.
| Branham investigates Pfizer for packaging error recall | | 4 | Pharma Bus Review |
| 09.02.
| Iowa businessman sentenced for selling fake Viagra | | - | Yahoo-USA |
| 09.02.
| Branham Law Group Investigates Pfizer for Qualitest Packaging Error Recall | | 94 | Business Wire |
| Branham
Law Group, LLP, a Dallas, Texas law firm, is
investigating Pfizer (NYSE: PFE) for its recall of 14 lots of
Lo/Ovral-28 tablet packs and 14 lots of generic...
Mehr lesen zu:
Branham Law Group Investigates Pfizer for Qualitest Packaging Error Recall | |
| 09.02.
| Pfizer Breaks Through Resistance at $21.11 | | 4 | SmarTrend |
| 09.02.
| The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer | | 31 | PR Newswire |
| CHICAGO, Feb. 9, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer | |
| 09.02.
| Apothecary to distribute Pfizer Inlyta drug | | 5 | Pharma Bus Review |
| 08.02.
| Pfizer Selects Biologics, Inc. as Limited Distribution Network Partner (LDN) | | 79 | Business Wire |
| Biologics, Inc., an integrated oncology services company has been
selected as a Limited Distribution Network (LDN) partner for Pfizer's
Inlyta which was approved by the...
Mehr lesen zu:
Pfizer Selects Biologics, Inc. as Limited Distribution Network Partner (LDN) | |
| 08.02.
| Boehringer Ingelheim/Pfizer's Spiriva Has Earned Decision Resources' Proprietary Clinical Gold Standard Status for the Treatment of Chronic Obstructive Pulmonary Disease | | 52 | Business Wire |
| The COPD Drug Market Will Increase from Approximately $8 Billion
in 2010 to $13 Billion in 2020, According to Findings from Decision
Resources
...
Mehr lesen zu:
Boehringer Ingelheim/Pfizer's Spiriva Has Earned Decision Resources' Proprietary Clinical Gold Standard Status for the Treatment of Chronic Obstructive Pulmonary Disease | |
| 08.02.
| Blue Chip Dividend Plays Losing Appeal in 2012 / The Paragon Report Provides Equity Research on 3M and Pfizer | | 36 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 02/08/12 -- With the S&P 500 skyrocketing in the early stages of 2012, investors are shifting away from dividend-paying stocks. According to a recent article from The...
Mehr lesen zu:
Blue Chip Dividend Plays Losing Appeal in 2012 / The Paragon Report Provides Equity Research on 3M and Pfizer | |
| 08.02.
| Nestle in lead to scoop up Pfizer's S$12.4b baby formula unit | | 21 | TODAYonline |
| 07.02.
| The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca | | 61 | PR Newswire |
| CHICAGO, Feb. 7, 2012 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca | |
| 07.02.
| DEALTALK-Nestle in lead to scoop up Pfizer's baby formula unit | | 8 | Reuters.com |
| 07.02.
| Pfizer sells animal health division for Rs 440cr | | 18 | moneycontrol.com |
| 07.02.
| Pfizer board approves sale of animal healthcare biz to subsidiary | | 17 | Myiris |
| 07.02.
| India's Pfizer to spin-off animal healthcare business | | 14 | Reuters.com |
| 07.02.
| Pfizer's Breast-Cancer Drug Worsens Bone Loss in Older Women | | 7 | Bloomberg |
| 06.02.
| Here's How Pfizer May Be Failing You | | 14 | Motley Fool |
